ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

2020 - FDA's Medical Device Software Regulation Strategy

Date2020-02-13 - 2020-02-14

Deadline2020-02-03

VenueSan Diego, CA, USA - United States USA - United States

KeywordsSeminar by Ex-FDA Official; FDA mobile apps regulation; Proprietary software

Websitehttps://www.complianceonline.com/fda-med...esearchbib

Topics/Call fo Papers

The development and application of medical device software expands faster than can be managed by one federal agency. Although FDA relies on its own experience and expertise, input from other federal organizations, voluntary standards organizations and partnerships with industry has become a collaborative effort. At the same time, the device software industry needs to look beyond FDA itself to understand where FDA will eventually go in regulating software.
The evolution of software has created unprecedented progress and unprecedented risks to the public. The management of the unprecedented risks requires the device industry to rely on more than just FDA’s guidance to comply with its regulatory expectations. FDA can expect developers to apply voluntary standards, such as ANSI, AAMI, IEC and ISO, all of which provide information on software verification and validation. The National Institute of Standards and Technology (NIST) has taken a leading role in publishing reports concerning the benefits and risks of third-party mobile applications. FDA has partnered with NIST in this effort. Likewise, NIST has published a report on cybersecurity management and wireless technology.
FDA recently published a draft guidance to help the industry address software issues in premarket submissions. The guidance sets out a baseline from which to show the adequacy of the software, but it is not an endpoint for you. Are you prepared to integrate and apply new software risk management tools for your devices?
FDA's risk classification will gradually clarify how it intends to manage the health risks. Risk factors include areas such as the following:
Cybersecurity
Interoperability
Mobile medical apps
Home use
Remote use
Software problems represent one of the most common root causes for recalls and have been associated with deaths and serious injuries as well. FDA sees firms revise software only to have it create more problems rather than solve them. The infusion pump industry is a classic example.

Last modified: 2020-01-14 15:04:09